Nanomed Pharameceuticals
Kalamazoo, Michigan, United States
About Nanomed Pharameceuticals
NanoMed Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutic products to treat cancer and other diseases. The company offers films and gels that include thin-film composites, which is a bi-layer film that promotes adherence to the skin and mucosal surfaces; film-forming gels, which is a water-based polymer that forms a dry thin film when applied topically to skin or a wet mucosal surface; and bioadhesive berry gel, which is applied to induce regression, prevent recurrence, and inhibit progression in persons with oral epithelial dysplasia. It develops drugs for treating various therapeutic diseases, such as breast, lung, head, neck, gastric, and prostate cancer.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.0M
- Last round: Series Unknown (Apr 2009)
- Website: nanomedpharm.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Pharmaceutical, Therapeutics
Canonical: https://fsome.com/organization/nanomed-pharameceuticals-2585677 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.